扩大帕金森病的视野:走向综合护理和全面研究
1Research Department, Consorci Sanitari de l'Alt-Penedès i Garraf, 08720 Barcelona, Spain.
Journal of clinical medicine
|January 25, 2025
概括
帕金森病 (PD) 是一个日益严重的全球健康问题. 本研究探讨了PD的关键方面,以了解其日益增长的影响.
科学领域:
- 神经科学是一个神经科学.
- 流行病学 流行病学
- 神经学 神经学
背景情况:
- 帕金森病 (PD) 是全球第二大神经退行性疾病.
- 在全球范围内,PD正在经历患病率,残疾和死亡率最快的增长.
- 了解PD的发展轨迹对于公共卫生战略至关重要.
研究的目的:
- 分析目前帕金森病的流行病学趋势.
- 确定导致PD患病率和死亡率上升的因素.
- 为未来的研究和临床干预提供见解.
主要方法:
- 全球流行病学数据的系统审查.
- 对PD相关的人口和临床数据的分析.
- 统计建模以预测未来的趋势.
主要成果:
- 证实PD是增长最快的神经系统疾病.
- 确定了主要的人口统计和风险因素相关性.
- 量化了PD对医疗保健系统日益增加的负担.
结论:
- 迫切需要采取全球行动,以应对帕金森病不断升级的影响.
- 对预防和治疗的进一步研究是必不可少的.
- 公共卫生倡议必须适应PD的日益流行.
相关概念视频
Parkinson's Disease: Treatment
194
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
194
Parkinson's Disease: Overview
451
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
451
Chronic Pancreatitis II: Collaborative Care
67
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
67
Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
Nursing Clinical Information System
748
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
748
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439


